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metabolic milieu that accelerates atherosclerosis, valvular disease,
heart failure, and arrhythmias, which invariably leads to higher
rates of cardiac and noncardiac death. Having recognized chronic
kidney disease (or impaired renal organ reserve) as an independent
cardiovascular risk state, the real challenges now are to develop new
diagnostic and therapeutic targets to better care for this rapidly
growing segment of our cardiovascular population.
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Heart Rate Recovery After Exercise
Is Not Demonstrated as a Predictor of
Mortality: Maybe After Treadmill-Exercise
Regarding the elegant and innovative study by Vivekananthan et
al., entitled “Heart Rate Recovery After Exercise Is a Predictor of
Mortality, Independent of the Angiographic Severity of Coronary
Disease” recently published in JACC (1), I must object that the title
of such a good report is substantially wrong. In fact, the word
“exercise” should have been more precisely substituted with the
words “treadmill-exercise.” This is definitely not a trivial correc-
tion, for no study has ever demonstrated that heart rate recovery
(HRR) after any type of exercise other than treadmill has any
relation with mortality. My group has completed a study of 1-min
HRR after cycloergometer-exercise test as a predictor of mortality
in a cohort of 1,420 real-life exercise-test candidates; we found
substantial differences compared to the treadmill-derived parame-
ter. I can surely state that no evidence has ever been published in
the peer-reviewed medical literature linking HRR and mortality
using any exercise modality other than treadmill-exercise. This
should be emphasized, as many clinicians could be tempted to
apply these results to other clinical exercise settings.
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REPLY
Dr. Gaibazzi is correct in stating that current evidence linking
heart rate recovery with death has been derived from cohorts of
patients undergoing treadmill-exercise testing. As previous work
has shown that heart rate responses during exercise are different
when using a bicycle (1), it will be important to perform future
research involving very large cohorts of patients undergoing this
type of test modality. Of note, recent work has shown that vagal
activity plays an important role in heart rate recovery after mental
stress (2), suggesting that the concept linking heart rate recovery
with prognosis may transcend the type of stress.
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Pulmonary Venous Flow by Doppler
Echocardiography: Usefulness
of Diastolic Wave Deceleration
Time in Predicting Filling Pressures
I read with great interest the study by Tabata et al. (1), which
reviews all the current applications of measuring pulmonary venous
flow by Doppler echocardiography. As reported by the investiga-
tors, measurement of pulmonary capillary pressure and left
ventricular end-diastolic pressure may utilize either the systolic
fraction or the difference between pulmonary venous atrial reverse-
wave duration and mitral inflow atrial-wave duration. Noninvasive
assessment of filling pressures with Doppler methods represents a
promising tool in diagnosing and monitoring heart failure (2);
thus, it appears of interest to point out the clinical usefulness of the
deceleration time of the pulmonary venous diastolic flow, which
has been well correlated to invasive pulmonary capillary pressure in
several studies regardless of left ventricular systolic function and
rhythm (3–7). Furthermore, a recent work by Kinnaird et al. (8)
has reported its better accuracy than the pulmonary artery occlu-
sion pressure in predicting left atrial pressure. At present, the
usefulness of the deceleration time of pulmonary venous diastolic
flow is limited in practice by the difficulty to record the pulmonary
venous flow from apical windows in critically ill patients (7);
nevertheless, the steady improvement of the quality of Doppler
echocardiographs will increase its feasibility in the coming years.
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REPLY
We thank Drs. Arques and Roux for their comments concerning
the increasing use of the deceleration time of the pulmonary
venous early diastolic flow (PV-DT) in published reports. We
agree that the PV-DT is a useful tool for estimating pulmonary
capillary wedge pressure (PCWP) as a measure of the left ventric-
ular (LV) filling pressure, especially in patients with normal sinus
rhythm. As mentioned in our study (1), it is important to recognize
the influence of several factors regarding use of pulmonary venous
flow velocities in clinical practice.
When evaluating PV-DT to estimate PCWP, the influences of
heart rate, mitral regurgitation (MR), atrial fibrillation (AF), and
LV systolic function have to be taken into account. Of those
factors, heart rate may have the largest influence on the PV-DT.
Chirillo et al. (2) specifically paid attention to the two components
of the deceleration slope of PV-DT. They speculated that the first
component was mainly dependent on the initial driving pressure of
the pulmonary venous flow, and the second component was
affected by the duration of LV relaxation, LV compliance, and
heart rate as reported by Little et al. (3). They found a strong
correlation between the initial deceleration slope of PV-DT and
PCWP during chronic AF with controlled ventricular rates. With
faster heart rates, it would be difficult to separate the first and
second components. Thus, PV-DT can estimate PCWP only
when the heart rates are relatively slow. Matsukida et al. (4) have
also reported that the PV-DT accurately predicted PCWP in
patients with AF, whereas they only included patients with a heart
rate of 60 to 80 beats/min. Both of the above investigators (2,4)
excluded patients with AF and a rapid ventricular rate. It is well
recognized that the loading conditions during AF are constantly
changing; therefore, even when an average of consecutive several
cardiac cycles of PV-DT is used, the value would vary depending
on the selected beats.
The final issue is the effect of MR. Pozzoli et al. (5) reported
that the PCWP can be reliably estimated by combining mitral
inflow and pulmonary venous flow velocities even when MR was
present. Although they have not evaluated PV-DT, the investiga-
tors have reported that the correlation between mitral deceleration
time and PCWP was stronger in patients without MR. Further-
more, they have limited their results to apply to patients without
atrial arrhythmias or tachycardia.
Thus, we conclude that the evaluation of the PV-DT for
estimating PCWP is most useful in patients without MR with
sinus rhythm and a relatively slower heart rate. As suggested by
Drs. Arques and Roux, we believe that the improvement in the
quality of pulmonary venous Doppler flow profile obtained by
transthoracic techniques will enhance the future use of PV flow in
clinical practice.
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Glycoprotein IIb/IIIa Inhibitors
and the Guidelines for Treatment of
Non–ST-Elevation Myocardial Infarction
In a recent study published in the Journal (1) Peterson et al. found
that with regard to use of glycoprotein (GP) IIb/IIIa inhibitors
there was a low adherence to American College of Cardiology/
American Heart Association guidelines (published in 2000) for
treatment of non–ST-elevation myocardial infarction (2), and they
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